公司资料

Si-Bone 股价、新闻与催化剂

股票代码:
SIBN
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

18.69 USD (-1.27%)

收盘价

最后更新: 2026年8月17日

621M USD

市值

股价为何变动

As of Aug 17, 2026, SIBN closed down 1.27% at $18.69. No new same-company headline was identified in the current news window.

公司概览

Spinopelvic Procedural Solutions

SI-BONE is a global medical-device company developing procedural solutions for patients with compromised bone, with a particular focus on the sacropelvic and spinopelvic anatomy.

iFuse Technology Platform

Its portfolio is built around the iFuse family of implants and instruments. Products include solutions for sacroiliac-joint fusion, pelvic trauma and complex spinal-fusion procedures, including iFuse TORQ, iFuse TORQ TNT and iFuse Bedrock Granite. SI-BONE supports adoption through physician education, dedicated sales territories and procedure-specific product development. The company sells in the United States and is expanding selected products into international markets.

未来催化剂

    近期新闻

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。